Viewing Study NCT07235202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-25 @ 5:39 PM
Study NCT ID: NCT07235202
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
Sponsor: Shenzhen Majory Biotechnology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma (PDAC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MR001 View
None PDAC View
None CD4 View
None TGF-β1 View